[go: up one dir, main page]

MX2019003298A - Proteinas de union recombinantes y sus usos. - Google Patents

Proteinas de union recombinantes y sus usos.

Info

Publication number
MX2019003298A
MX2019003298A MX2019003298A MX2019003298A MX2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A MX 2019003298 A MX2019003298 A MX 2019003298A
Authority
MX
Mexico
Prior art keywords
binding proteins
recombinant binding
nucleic acids
proteins
binding
Prior art date
Application number
MX2019003298A
Other languages
English (en)
Other versions
MX377424B (es
Inventor
Fiedler Ulrike
DOLADO Ignacio
Metz Clara
Maria STROBEL Heike
Original Assignee
Molecular Partners Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Partners Ag filed Critical Molecular Partners Ag
Publication of MX2019003298A publication Critical patent/MX2019003298A/es
Publication of MX377424B publication Critical patent/MX377424B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se desvelan nuevas proteínas de unión recombinantes, que comprenden dominios diseñados con repeticiones de anquirina con especificidad de unión para el HER2, y que comprenden dominios diseñados con repeticiones de anquirina con especificidad de unión para la seroalbúmina, así como los ácidos nucleicos que codifican dichas proteínas de unión recombinantes, composiciones farmacéuticas que comprenden dichas proteínas de unión recombinantes o ácidos nucleicos y el uso de dichas proteínas de unión recombinantes, ácidos nucleicos o composiciones farmacéuticas en el tratamiento de enfermedades.
MX2019003298A 2016-09-22 2017-09-20 Proteinas de union recombinantes y sus usos MX377424B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16190221 2016-09-22
PCT/EP2017/073768 WO2018054971A1 (en) 2016-09-22 2017-09-20 Recombinant binding proteins and their use

Publications (2)

Publication Number Publication Date
MX2019003298A true MX2019003298A (es) 2019-09-26
MX377424B MX377424B (es) 2025-03-10

Family

ID=57046984

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003298A MX377424B (es) 2016-09-22 2017-09-20 Proteinas de union recombinantes y sus usos

Country Status (20)

Country Link
US (2) US10717772B2 (es)
EP (1) EP3515933B9 (es)
JP (1) JP6976335B2 (es)
KR (1) KR102270315B1 (es)
CN (1) CN109790206A (es)
AR (1) AR109680A1 (es)
AU (1) AU2017331329B2 (es)
BR (1) BR112019005587A2 (es)
CA (1) CA3036301C (es)
CL (1) CL2019000729A1 (es)
CO (1) CO2019002609A2 (es)
ES (1) ES2953516T3 (es)
IL (1) IL265489B (es)
MX (1) MX377424B (es)
MY (1) MY196882A (es)
NZ (1) NZ751689A (es)
PH (1) PH12019500596B1 (es)
SA (1) SA519401369B1 (es)
WO (1) WO2018054971A1 (es)
ZA (1) ZA201901592B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021553000A1 (en) * 2019-06-04 2023-08-23 Molecular Partners Ag Multispecific proteins
CN114206908B (zh) 2019-06-04 2025-12-23 分子伴侣公司 具有改善的稳定性的经设计的锚蛋白重复结构域
AU2020286600A1 (en) * 2019-06-04 2021-12-23 Molecular Partners Ag Recombinant FAP binding proteins and their use
JP2022535107A (ja) * 2019-06-04 2022-08-04 モレキュラー パートナーズ アクチェンゲゼルシャフト 組換え4-1bb結合タンパク質及びそれらの使用
BR112022011456A2 (pt) 2019-12-11 2022-08-23 Molecular Partners Ag Proteínas recombinantes de ligação a complexo de peptídeo-mhc e geração e uso das mesmas
CA3176845A1 (en) 2020-05-06 2021-11-11 Patrick AMSTUTZ Novel ankyrin repeat binding proteins and their uses
JP2023528207A (ja) * 2020-05-14 2023-07-04 モレキュラー パートナーズ アクチェンゲゼルシャフト 組換えcd40結合タンパク質及びそれらの使用
EP4149959A1 (en) 2020-05-14 2023-03-22 Molecular Partners AG Multispecific proteins
EP4263607A1 (en) 2020-12-16 2023-10-25 Molecular Partners AG Novel slow-release prodrugs
US20240317852A1 (en) 2021-03-09 2024-09-26 Molecular Partners Ag Novel darpin based cd33 engagers
EP4304729A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Novel darpin based cd123 engagers
US11834504B2 (en) 2021-03-09 2023-12-05 Molecular Partners Ag DARPin based multi-specific t-cell engagers
CA3211242A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Protease cleavable prodrugs
AU2022413461A1 (en) 2021-12-14 2024-06-06 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
IL318514A (en) 2022-08-01 2025-03-01 Molecular Partners Ag Loading and using modified re-designed websites
WO2024038307A1 (en) 2022-08-19 2024-02-22 Novartis Ag Dosing regimens for sars-cov-2 binding molecules
AU2024221136A1 (en) 2023-02-17 2025-10-02 Ablynx N.V. Polypeptides binding to the neonatal fc receptor
WO2024179981A1 (en) 2023-02-27 2024-09-06 Molecular Partners Ag Darpins for use in reducing renal accumulation of drugs
WO2024251628A1 (en) 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
AU2024286934A1 (en) 2023-06-06 2025-12-18 Molecular Partners Ag Recombinant cd2 binding proteins and their use
WO2025146487A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Multispecific binding proteins
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
WO2025163144A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager
WO2026013280A1 (en) * 2024-07-11 2026-01-15 Johann Wolfgang Goethe-Universität Frankfurt am Main Designed ankyrin repeat proteins binding p53, and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US7371376B1 (en) 1996-10-18 2008-05-13 Genentech, Inc. Anti-ErbB2 antibodies
ATE448301T1 (de) 2000-09-08 2009-11-15 Univ Zuerich Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
EP1567641B1 (en) * 2001-08-24 2012-05-23 UVic Industry Partnerships Inc. Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
NZ554429A (en) 2004-11-12 2010-08-27 Bayer Schering Pharma Ag Recombinant newcastle disease virus comprising a transgene encoding a antibody or antibody like fragment or derivative thereof for use in cancer treatments
AU2006268780B2 (en) 2005-07-08 2011-03-24 University Of Zurich Phage display using cotranslational translocation of fusion polypeptides
JP2010539915A (ja) 2007-09-24 2010-12-24 ユニバーシティ・オブ・チューリッヒ 設計されたアルマジロリピートタンパク質
MX2010005783A (es) 2007-11-27 2010-08-10 Ablynx Nv Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas.
BRPI0921469B1 (pt) 2008-11-03 2022-01-18 Molecular Partners Ag Proteínas de ligação que inibem a interação com o receptor de vegf-a, composição farmacêutica
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP2643349B1 (en) * 2010-11-26 2019-09-04 Molecular Partners AG Designed repeat proteins binding to serum albumin
EA201391607A1 (ru) 2011-04-29 2014-04-30 Янссен Байотек, Инк. Связывающие il4/il13 белки с повторами и их применение
HK1209156A1 (en) 2012-06-28 2016-03-24 分子伴侣公司 Designed ankyrin repeat proteins binding to platelet-derived growth factor
US10093740B2 (en) * 2012-10-15 2018-10-09 Universitat Zurich Bispecific HER2 ligands for cancer therapy
EP2738180A1 (en) * 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
JP6486908B2 (ja) 2013-05-31 2019-03-20 モレキュラー パートナーズ アクチェンゲゼルシャフト 肝細胞増殖因子に結合する設計アンキリン反復タンパク質
PH12017501792B1 (en) 2015-04-02 2022-07-20 Molecular Partners Ag Recombinant binding proteins and their use

Also Published As

Publication number Publication date
ZA201901592B (en) 2021-04-28
JP6976335B2 (ja) 2021-12-08
CN109790206A (zh) 2019-05-21
EP3515933B1 (en) 2023-06-07
SA519401369B1 (ar) 2022-12-22
MX377424B (es) 2025-03-10
RU2019111628A (ru) 2020-10-19
EP3515933A1 (en) 2019-07-31
RU2019111628A3 (es) 2020-10-30
IL265489A (en) 2019-05-30
PH12019500596B1 (en) 2024-02-21
JP2019531093A (ja) 2019-10-31
CA3036301C (en) 2021-04-20
WO2018054971A1 (en) 2018-03-29
EP3515933B9 (en) 2023-08-16
CA3036301A1 (en) 2018-03-29
CO2019002609A2 (es) 2019-05-31
KR20190050802A (ko) 2019-05-13
KR102270315B1 (ko) 2021-06-29
AR109680A1 (es) 2019-01-09
IL265489B (en) 2021-07-29
AU2017331329A1 (en) 2019-04-04
EP3515933C0 (en) 2023-06-07
NZ751689A (en) 2021-07-30
US20210130420A1 (en) 2021-05-06
MY196882A (en) 2023-05-08
AU2017331329B2 (en) 2020-10-29
US10717772B2 (en) 2020-07-21
CL2019000729A1 (es) 2019-06-14
US20180155402A1 (en) 2018-06-07
ES2953516T3 (es) 2023-11-14
PH12019500596A1 (en) 2019-07-29
BR112019005587A2 (pt) 2019-06-11

Similar Documents

Publication Publication Date Title
CO2019002609A2 (es) Proteínas de unión recombinantes y sus usos
CO2017009954A2 (es) Dominios diseñados con repeticiones de anquirina con especificidad de unión para la seroalbúmina
CL2020002043A1 (es) Métodos y composiciones para la entrega de proteínas terapeuticas.
CL2022000300A1 (es) Muteínas de interleucina 21 y sus usos para tratar tumores sólidos (divisional de la solicitud no. 202000252)
CL2022000036A1 (es) Polipéptidos modificados y usos de los mismos (divisional de solicitud no. 201900261)
CL2018003136A1 (es) Proteínas de unión específica y usos de las mismas.
BR112018072946A2 (pt) proteínas de fusão a gdf15 e usos das mesmas
AR115389A1 (es) Anticuerpo antagonista de cd73
BR112018068189A2 (pt) proteínas de ligação induzíveis e métodos de uso
MX2017010117A (es) Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso.
MX2017008817A (es) Composiciones y metodos para la glicosilacion de proteinas.
CL2018003438A1 (es) Anticuerpos a la alfa-sinucleína y usos de los mismos.
MX2017014908A (es) Proteinas de union triespecificas y metodos de uso.
AR111288A1 (es) Anticuerpos anti-phf-tau y sus usos
EA201700181A1 (ru) Композиции аденозиндеаминазы-2 (ада-2), их варианты и способы использования
BR112019008351A2 (pt) imunoglobulinas e usos das mesmas
CL2017002881A1 (es) Anticuerpos anti-fcrn
CO2020000369A2 (es) Polipéptidos que se unen al componente del complemento c5 o albumina sérica y proteínas de fusión de los mismos
MX2020004801A (es) Polipeptidos de fusion biespecificos y sus metodos de uso.
MX2021004925A (es) Variantes de adn-polimerasa modificadas.
BR112019010128A2 (pt) proteínas de ligação a antígeno anti-gitr e métodos de uso das mesmas
MX2018003445A (es) Expresion de proteinas que contienen fc.
BR112019007343A2 (pt) sequência de nucleotídeos expressando uma proteína de ancoragem de exossomo para uso como vacina
AR103294A1 (es) Composiciones y procedimientos para la glicosilación de proteínas

Legal Events

Date Code Title Description
FG Grant or registration